HOME JOURNALS CONTACT

International Journal of Pharmacology

Year: 2005 | Volume: 1 | Issue: 2 | Page No.: 180-184
DOI: 10.3923/ijp.2005.180.184
Lornoxicam Inhibits Human Polymorphonuclear Cell Migration Induced by fMLP, Interleukin-8 and Substance P
Paola Sacerdote and Mauro Bianchi

Abstract: It has been established that nonsteroidal anti-inflammatory drugs (NSAIDs) have additional mechanisms of action, besides the inhibition of prostanoid production. We evaluated the ability of lornoxicam, a novel NSAID of the oxicam family, to interfere with the migration of human polymorphonuclear cells (PMN) in vitro. PMN were obtained from healthy donors. Chemotaxis was assessed by a Boyden microchemotaxis chamber and was stimulated with the bacterial chemoattractant formyl-met-leu-phe (fMLP, 0.1 μM), the chemokine Interleukin-8 (25 ng mL -1, 0.003 μM) or the neuropeptide substance P (0.1 μM). Lornoxicam was used at the concentrations of 0.01, 1.0 and 100 μM. This NSAID inhibited fMLP and Substance P chemotaxis starting from the concentration of 1.0 μM, whereas Interleukin-8-induced chemotaxis was significantly reduced also at 0.01 μM. As these concentrations can be easily reached in plasma and in the synovial fluid after the administration of this drug in vivo, present data suggest that the inhibition of neutrophil migration is involved in the anti-inflammatory action of lornoxicam.

Fulltext PDF

How to cite this article
Paola Sacerdote and Mauro Bianchi, 2005. Lornoxicam Inhibits Human Polymorphonuclear Cell Migration Induced by fMLP, Interleukin-8 and Substance P. International Journal of Pharmacology, 1: 180-184.

Keywords: .

REFERENCES
  • Ben-Baruch, A., D.F. Michiel and J.J. Oppenheim, 1995. Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem., 270: 11703-11706.
    PubMed    

  • Mantovani, A., 1999. The chemokine system: redundancy for robust outputs. Immunol. Today, 20: 254-257.

  • Locatelli, L., P. Sacerdote, P. Mantegazza and A.E. Panerai, 1993. Effect of ibuprofen and diclofenac on the chemotaxis induced by substance P and transforming growth factor beta on human monocytes and polymorphonuclear cells. Int. J. Immunopharmacol., 15: 833-838.

  • Prossnitz, E.R. and R.D. Ye, 1997. The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function. Pharmacol. Ther., 74: 73-102.

  • Kankaanranta, H., E. Moilanen and H. Vapataalo, 1994. Effects of non steroidal antiinflammatory drugs on polymorphonuclear leukocyte function in vitro: Focus on fenamates. Naunyn Schmiedeberg's Arch. Pharmacol., 350: 685-691.

  • Diaz-Gonzales, F. and F. Sanchez-Madrid, 1998. Inhibition of leukocyte adhesion: An alternative mechanism of action of anti-inflammatory drugs. Immunol. Today, 4: 169-172.
    Direct Link    

  • Panerai, A.E., L. Locatelli and P. Sacerdote, 1992. Effect of piroxicam and ibuprofen on SP induced chemotaxis of human monocytes and polymorphonuclear cells. Pharmacol. Res., 26: 30-31.

  • Hascelik, Z., G. Hascelik, R. Celiker and M. Ozalp, 1994. Effects of tenoxicam on neutrophil chemotaxis in rheumatoid arthritis and healthy controls. Clin. Rheumatol., 13: 98-102.

  • Bizzarri, C., S. Pagliei, L. Brandolini, P. Mascagni, G. Caselli, P. Transidico, S. Sozzani and R. Bertini, 2001. Selective inhibition of interleukin-8 induced neutrophils chemotaxis by ketoprofen isomers. Biochem. Pharmacol., 61: 1429-1437.

  • Sacerdote, P. and A.E. Panerai, 1993. Effect of tenoxicam and indomethacin on the chemotaxis induced by Substance P and interleukin-8 on human monocytes and polymorphonuclear cells. Int. J. Tissue React., 15: 175-180.

  • Balfour, J.A., A. Fitton and L.B. Barradell, 1996. Lornoxicam: A review of its pharmacology and therapeutical potential in the management of painful and inflammatory conditions. Drugs, 51: 639-657.

  • Berg, J., H. Fellier, T. Cristoph, J. Grarup and D. Stimmeder, 1999. The analgesic NSAID lornoxicam inhibit cyclooxygenase Cox1/2 inducible nitric oxide synthase (iNOS) and the formation of interleukin-6 (IL-6) in vitro. Inflammat. Res., 48: 369-379.

  • Bianchi, M. and A.E. Panerai, 2002. Effects of lornoxicam, piroxicam and meloxicam in a model of thermal hindpaw hyperalgesia induced by formalin injection in rat tail. Pharmacol. Res., 45: 101-105.

  • Buritova, J. and J.M. Besson, 1998. Dose-related anti-inflammatory/analgesic effects of lornoxicam: A spinal c-Fos protein study in the rat. Inflammat. Res., 47: 18-25.

  • Rosenov, D.E., F. van Krieken, D. Stolke and F. Kursten, 1996. Intravenous administration of lornoxicam, a new NSAID and pethidine for post-operative pain a placebo controlled pilot study. Clin. Drug Invest., 11: 11-19.

  • Visalyaputra, S., V. Sanansilp, N. Pechpaisit, R. Choavarartana and S. Sritisarn et al., 2002. Post operative analgesic effect of intravenous lornoxicam and morphine with pre-emptive ropivacaine skin infiltration and preperitoneal instillation after transabdominal hysterectomy. J. Med. Assoc. Thai, 3: 1010-1016.

  • Wenzel-Seifert, K., O.C.M. Hurt and R. Seifert, 1998. High constitutive activity of the human formyl peptide receptor. J. Biol. Chem., 273: 24181-24189.

  • Seitz, M., B. Dewald, N. Gerber and M. Baggiolini, 1990. Enhanced production of neutrophil activating peptide-1/interleukin-8 in rheumatoid arthritis. J. Clin. Invest., 87: 463-468.

  • Endo, H., T. Akahoshi, K. Takagishi, S. Kashivwazaki and K. Matsushima, 1991. Elevation of IL-8 levels in joint fluid of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphocyte Cytokine Res., 10: 245-249.

  • Lotz, M., D.A. Carson and N.J. Vaughan, 1985. Substance P activation in rheumathoid synoviocytes: Neural pathway in pathogenesis of arthritis. Science, 235: 893-895.

  • Lotz, M., J. Vaughan and D. Carson, 1998. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science, 241: 1218-1221.

  • Sacerdote, P., M. Carrabba, A. Galante, R. Pisati, B. Manfredi and A.E. Panerai, 1995. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: Effect of the non steroidal anti inflammatory drugs indomethacin, diclofenac and naproxen. Inflammat. Res., 44: 486-490.

  • Marshal, K.W., B. Chiu and R.D. Inman, 1990. Substance P analysis of plasma and synovial fluid levels. Arthritis Rheum, 33: 87-91.

  • Bianchi, M.M., Broggini, P. Balzarini, E. Baratelli, P. Ferrario, A.E. Panerai and P. Sacerdote, 2003. Effects of tramadol on synovial fluid concentrations of substance P and Interleukin-6 in patients with knee osteoarthritis: Comparison with paracetamol. Int. Immunopharmacol., 3: 1901-1908.
    CrossRef    

  • Sacerdote, P., M. Bianchi and A.E. Panerai, 1994. Chlorimipramine and nortryptiline, but not fluoxetine and fluvoxamine, inhibit human polymorphonuclear cell chemotaxis in vitro. Gen. Pharmacol., 25: 409-412.

  • Abramson, S.H., H.K. Edelson, R. Ledewig and G. Weissman, 1989. The mechanism of action of nonsteroidal anti-inflammatory drugs. Arthritis Rheum, 32: 1-9.

  • Shubitz, K. and D. Hammerschmidt, 1986. Effect of ibuprofen on chemotactic peptide-receptor binding and granulocyte response. Biochem. Pharmacol., 35: 3349-3354.

  • Abramson, S.B., J. Leszczynska-Piziak, R.M. Clancy, M. Philips and G. Weissmann, 1994. Inhibition of neutrophil function by aspirin like drugs (NSAIDs): Requirement for assembly of heterotrimeric G proteins in bilayer phospholipid. Biochem. Pharmacol., 47: 563-572.

  • Quartara, L. and C.A. Maggi, 1997. The tachykinin NK1 receptor. Part 1: Ligands and mechanisms of cellular activation. Neuropeptides, 31: 537-563.

    • © Science Alert. All Rights Reserved